Bank Of America Corp Gossamer Bio, Inc. Transaction History

Bank Of America Corp

$1.43 Trillion
Q3 2025

A detailed history of Bank Of America Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,881,904 shares of GOSS stock, worth $7.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,881,904

Previous 67,080 4196.22%

Holding current value

$7.81 Million

Previous $82,000 9142.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.21 - $3.46 $3.41 Million - $9.74 Million	2,814,824 Added 4196.22%	2,881,904 $7.58 Million
Q2 2025 Aug 14, 2025	SELL	$0.78 - $1.44 $75,465 - $139,320	-96,750 Reduced 59.06%	67,080 $82,000
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $67,185 - $120,934	79,042 Added 93.22%	163,830 $180,000
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $28,951 - $46,936	43,866 Added 107.19%	84,788 $76,000
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $1,078 - $1,706	-1,365 Reduced 3.23%	40,922 $40,000

Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $39,616 - $98,652	-77,679 Reduced 64.75%	42,287 $38,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $30,608 - $57,774	38,261 Added 46.83%	119,966 $141,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $10,644 - $23,950	-22,176 Reduced 21.35%	81,705 $74,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $122,548 - $191,324	-125,049 Reduced 54.62%	103,881 $124,000
Q1 2023 May 12, 2023	SELL	$0.96 - $2.92 $2.7 Million - $8.22 Million	-2,814,377 Reduced 92.48%	228,930 $288,000
Q4 2022 Feb 10, 2023	BUY	$1.74 - $12.87 $4.67 Million - $34.6 Million	2,685,828 Added 751.32%	3,043,307 $6.6 Million
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $687,423 - $1.42 Million	-95,343 Reduced 21.06%	357,479 $4.28 Million
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $924,484 - $1.54 Million	154,855 Added 51.97%	452,822 $3.79 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $373,993 - $553,456	44,312 Added 17.47%	297,967 $2.59 Million
Q4 2021 Feb 08, 2022	BUY	$10.12 - $14.07 $1.62 Million - $2.25 Million	160,180 Added 171.36%	253,655 $2.87 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $145,036 - $264,666	20,005 Added 27.23%	93,475 $1.18 Million
Q2 2021 Sep 13, 2021	BUY	$8.0 - $9.75 $587,760 - $716,332	73,470 New	73,470 $597,000

Others Institutions Holding GOSS

# of Institutions

181

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Gossamer Bio, Inc. Transaction History